Long-term study: Robot-assisted prostate surgery is safe

March 23, 2011

In the first study of its kind, urologists and biostatisticians at Henry Ford Hospital have found that robot-assisted surgery to remove cancerous prostate glands is safe over the long term, with a major complication rate of less than one percent.

The findings, published online this month by the journal European Urology, follow an earlier Henry Ford study that found nearly 87 percent of patients whose cancerous prostates were removed by robot-assisted had no recurrence of the disease after five years.

"We have always felt that robotic surgery for prostate cancer was safe, but there have been no studies that have looked at long-term safety. This is why the Henry Ford study is so important," says Mani Menon, M.D., director of Henry Ford's Vattikuti Urology Institute.

The new research analyzed the of more than 3,000 consecutive patients at Henry Ford's Vattikuti Urology Institute from January 2005 to December 2009, and addressed "the lack of standardized reporting" that hampered previous published literature on complications of radical prostatectomy (RP).

In RP, the entire diseased and some surrounding tissue are surgically removed, in hopes of preventing the cancer from spreading to other parts of the body.

Henry Ford Hospital pioneered the use of robots to assist surgeons in the delicate procedure, and the new study notes that robot-assisted (RARP) is now the most common technique in the U.S. for treating localized .

The Henry Ford researchers found only one previous report on complications of RP that had adhered to uniform surgical reporting standards. However that study looked at open and laparoscopic prostatectomy, and did not include robot-assisted RP.

Confronted, in a sense, by "apples and oranges" comparisons of several RP surgical techniques, the Henry Ford researchers set out to produce a five-year safety study that both concentrated on RARP and incorporated an exhaustive collection of data, covering everything from length of hospital stay, to an in-depth examination of other diseases afflicting the patients, but unrelated to their cancers.

Among the study group of 3,317 RARP patients, researchers found a median hospitalization time of only one day. There were 368 complications in 326 of the patients – or 9.8 percent of the total – most of which were minor and occurred within 30 days of the surgery.

A patient's prostate-specific antigen (PSA) scores before surgery, as well as cardiac disease, were found to predict medical complications after the robot-assisted surgery; age, gastroesophageal reflux disease (GERD), and biopsy score predicted possible surgical complications.

The researchers' main conclusion was that "RARP is a safe operation."

Henry Ford's robot-assisted urology program uses a surgeon-controlled robot, the da Vinci minimally invasive surgery system.

It enables surgeons to manipulate robotic arms for precise procedures through a series of small incisions, instead of the large wounds required by traditional "open" surgery, and provides 3-D monitoring for the entire surgical team.

The potential benefits for the patient include shorter recovery times, less trauma, and reduced hospitalization costs.

It is also the basis of a "nerve-sparing" procedure called the Veil of Aphrodite, developed at Ford, to minimize the erectile dysfunction common in men after undergoing traditional radical .

"While these results provide strong endorsement for robotic surgery, we want to emphasize that the results are dependent more on the surgical team that controls the da Vinci robot rather than just the robot," Dr. Menon states.

Related Stories

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.